AI Stock Finder
Loading...
Skip to main content
AI Stock Finder · Updated Oct. 14, 2026

Starling Oncology, Inc. STLN Stock Forecast

AI-powered price prediction and analysis for Starling Oncology, Inc. · Alpha · vs marketSwitch to Total

Follow
AI 90-Day Forecast ▲ Exact rating locked
7 Days Sign up free to reveal
30 Days Sign up free to reveal
90 Days Sign up free to reveal
AI Confidence n/a Spearman Correlation

See STLN's Exact Price Target · Create a free account and follow this stock to unlock its full AI forecast — 3 stocks free.

Price

Price Chart

STLN
Fundamentals

Key Statistics

EPS$-0.47
Net Margin-6.2%
Revenue$587M
Current Ratio1.36x
Company

About Starling Oncology, Inc.

Starling Oncology, Inc. (STLN) operates within the Industrial Applications and Services sector, specifically in the Services-Offices & Clinics of Doctors of Medicine industry.

Industrial Applications and Services Services-Offices & Clinics of Doctors of Medicine Nasdaq
News

Latest News

  • Loading...

Where STLN sits on the market map

Industrial Applications and Services · Services-Offices & Clinics of Doctors of Medicine
Explore the map →
Industry Peers

Services-Offices & Clinics of Doctors of Medicine Peers

Companies sharing the same SEC industry code, one row per issuer, largest first - a classification match, not a curated list of competitors.

CompanyAI SignalMarket CapP/E
STLN Starling Oncology, Inc. ▲ N/A –
TDOC Teladoc Health, Inc. ▶ $1.09B –
SBC Sbc Medical Group Holdings … ▼ $547M 11.2x
LFMD Lifemd, Inc. ▲ $119M –
AIRS Airsculpt Technologies, Inc. ▲ $117M –
HLYK Healthlynked Corp ▲ $7M –
CDIX Cardiff Lexington Corp ▼ N/A –
HIMS Hims & Hers Health, … ▶ N/A –
FAQ

FAQ

Is Starling Oncology, Inc. a good stock to buy?

Our AI analyzes Starling Oncology, Inc. daily. Check the signal above for the latest recommendation. Always do your own research before investing.

How accurate are Starling Oncology, Inc. predictions?

A per-ticker accuracy statistic for STLN is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

How often are forecasts updated?

Starling Oncology, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.

Ready to invest smarter? · Join thousands of investors using AI-powered stock predictions

Sign Up Free

Looking for a deeper analysis of Starling Oncology, Inc.? View full institutional-grade analysis on Intratio →

AI predictions are based on historical patterns and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always do your own research.